Edition:
United Kingdom

Insider Trading: Achillion Pharmaceuticals Inc (ACHN.OQ)

ACHN.OQ on NASDAQ Stock Exchange Global Select Market

4.26USD
23 Aug 2019
Change (% chg)

$-0.31 (-6.78%)
Prev Close
$4.57
Open
$4.69
Day's High
$4.69
Day's Low
$4.21
Volume
645,378
Avg. Vol
425,227
52-wk High
$5.02
52-wk Low
$1.29

All Insider Trades
Trading Date Name Title Type Shares Traded Price
14 Dec 2018

Scheer (David I)

Director Buy 20,000 $1.05
14 Dec 2018

Van Nostrand (Robert L)

Director Buy 20,000 $1.05
6 Jun 2018

Fisherman (Jason S)

Director Buy 20,000 $1.05
31 May 2018

Vitullo (Nicole)

Director Sell 25,000 $0.00
31 May 2018

Vitullo (Nicole)

Director Buy 5,000 $0.00
20 Nov 2017

Johnson & Johnson Development Corporation

Beneficial Owner of More than 10% Class Sell 18,367,346 $2.75

Institutional Holders

% Shares Owned: 83.13%
# of Holders: 166
Total Shares Held: 116,124,872
3 Mo. Net Change: 1,060,165
# New Positions: 24
# Closed Positions: 13
# Increased Positions: 68
# Reduced Positions: 57
# Net Buyers: 11

Officers & Directors

Name Age Since Current Position

Nicole Vitullo

61 2019 Independent Chairman of the Board

Joseph Truitt

54 2018 President, Chief Executive Officer, Director

Brian Di Donato

52 2019 Chief Financial Officer, Senior Vice President

Paul Firuta

53 2018 Chief Operating Officer, Executive Vice President

Martha Manning

64 2016 Executive Vice President, General Counsel, Corporate Secretary

Anthony Gibney

48 2018 Executive Vice President, Chief Business Officer

Steven Zelenkofske

60 2018 Executive Vice President and Chief Medical Officer

Keri Lantz

44 2019 Vice President - Finance, Corporate Controller

Jason Fisherman

62 2000 Independent Director

Kurt Graves

51 2012 Independent Director

Michael Kishbauch

70 2016 Independent Director

David Scheer

66 2019 Independent Director

Robert Van Nostrand

62 2007 Independent Director

Frank Verwiel

56 2015 Independent Director

A. Clayton Robertson

2019 Manager, IR Contact Officer